Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018
出 版 商：Infiniti Research
出版日期：2014/08/20
頁 數：48頁
文件格式：PDF
價 格：
USD 2,000 (Single-User License)
USD 2,300 (Multi-User License)
USD 3,000 (Global-User License)
USD 2,300 (Multi-User License)
USD 3,000 (Global-User License)
About CRAMS
CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: contract research and contract manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.
TechNavio's analysts forecast the CRAMS market in India to grow at a CAGR of 32.67 percent over the period 2013-2018.
Covered in this Report
In terms of activities, the CRAMS market in India can be segmented into two: Contract Research and Contract Manufacturing. To calculate the market size, the report considers the revenue generated from the services offered by contract research and contract manufacturing organizations to other equipment manufacturers (OEMs) for the manufacturing of new chemical entities, API, and pre-clinical and clinical research.
TechNavio's report, the CRAMS Market in India 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the CRAMS market in India and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ India
Key Vendors
‧ Biocon
‧ Dishman Pharmaceuticals and Chemicals
‧ Divis Laboratories
‧ Jubilant Life Sciences
‧ Piramal Healthcare
Other Prominent Vendors
‧ Aurbindo Pharma
‧ Cadila Healthcare
‧ Dr. Reddy's Laboratories
‧ GVK Biosciences
‧ Ipca Laboratories
‧ Lupin
‧ Quintiles
‧ Siro Clinpharm
‧ Sun Pharmaceutical
‧ Wockhardt
Market Driver
‧ Rising Cost of Research in Developed Markets
‧ For a full, detailed list, view our report
Market Challenge
‧ Growing Global Competition
‧ For a full, detailed list, view our report
Market Trend
‧ Increase in Strategic Alliances
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: contract research and contract manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.
TechNavio's analysts forecast the CRAMS market in India to grow at a CAGR of 32.67 percent over the period 2013-2018.
Covered in this Report
In terms of activities, the CRAMS market in India can be segmented into two: Contract Research and Contract Manufacturing. To calculate the market size, the report considers the revenue generated from the services offered by contract research and contract manufacturing organizations to other equipment manufacturers (OEMs) for the manufacturing of new chemical entities, API, and pre-clinical and clinical research.
TechNavio's report, the CRAMS Market in India 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the CRAMS market in India and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ India
Key Vendors
‧ Biocon
‧ Dishman Pharmaceuticals and Chemicals
‧ Divis Laboratories
‧ Jubilant Life Sciences
‧ Piramal Healthcare
Other Prominent Vendors
‧ Aurbindo Pharma
‧ Cadila Healthcare
‧ Dr. Reddy's Laboratories
‧ GVK Biosciences
‧ Ipca Laboratories
‧ Lupin
‧ Quintiles
‧ Siro Clinpharm
‧ Sun Pharmaceutical
‧ Wockhardt
Market Driver
‧ Rising Cost of Research in Developed Markets
‧ For a full, detailed list, view our report
Market Challenge
‧ Growing Global Competition
‧ For a full, detailed list, view our report
Market Trend
‧ Increase in Strategic Alliances
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07. Benefit Analysis of CRAMS Market in India
07.1 Five Forces Analysis
08. Market Segmentation by Category
08.1 Contract Research Market in India
08.1.1 Market Size and Forecast
08.2 Contract Manufacturing Market in India
08.2.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
17. Competitive Assessment of Major Players
18. Key Vendor Analysis
18.1 Biocon Ltd.
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 Dishman Pharmaceuticals and Chemicals Ltd.
18.2.1 Business Overview
18.2.2 Business Segmentation
18.2.3 Key Information
18.2.4 SWOT Analysis
18.3 Divis Laboratories Ltd.
18.3.1 Business Overview
18.3.2 Key Information
18.3.3 SWOT Analysis
18.4 Jubilant Life Sciences Ltd.
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
18.5 Piramal Healthcare Ltd.
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: CRAMS Market in India 2013-2018 (US$ billion)
Exhibit 3: CRAMS Market in India Segmentation by Category
Exhibit 4: CRAMS Market in India by Market Segmentation 2013
Exhibit 5: Contract Research Market in India 2013-2018 (US$ billion)
Exhibit 6: Contract Manufacturing Market in India 2013-2108 (US$ billion)
Exhibit 7: CRAMS Market in India Segmentation by Category 2013-2018 (US$ billion)
Exhibit 8: CRAMS Market in India Segmentation by Category 2013-2018 (in percent)
Exhibit 9: Business Segmentation of Biocon Ltd.
Exhibit 10: Business Segmentation of Dishman Pharmaceuticals and Chemicals Ltd.
Exhibit 11: Business Segmentation of Jubiliant Life Sciences Ltd.
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07. Benefit Analysis of CRAMS Market in India
07.1 Five Forces Analysis
08. Market Segmentation by Category
08.1 Contract Research Market in India
08.1.1 Market Size and Forecast
08.2 Contract Manufacturing Market in India
08.2.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
17. Competitive Assessment of Major Players
18. Key Vendor Analysis
18.1 Biocon Ltd.
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 Dishman Pharmaceuticals and Chemicals Ltd.
18.2.1 Business Overview
18.2.2 Business Segmentation
18.2.3 Key Information
18.2.4 SWOT Analysis
18.3 Divis Laboratories Ltd.
18.3.1 Business Overview
18.3.2 Key Information
18.3.3 SWOT Analysis
18.4 Jubilant Life Sciences Ltd.
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
18.5 Piramal Healthcare Ltd.
18.5.1 Business Overview
18.5.2 Key Information
18.5.3 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: CRAMS Market in India 2013-2018 (US$ billion)
Exhibit 3: CRAMS Market in India Segmentation by Category
Exhibit 4: CRAMS Market in India by Market Segmentation 2013
Exhibit 5: Contract Research Market in India 2013-2018 (US$ billion)
Exhibit 6: Contract Manufacturing Market in India 2013-2108 (US$ billion)
Exhibit 7: CRAMS Market in India Segmentation by Category 2013-2018 (US$ billion)
Exhibit 8: CRAMS Market in India Segmentation by Category 2013-2018 (in percent)
Exhibit 9: Business Segmentation of Biocon Ltd.
Exhibit 10: Business Segmentation of Dishman Pharmaceuticals and Chemicals Ltd.
Exhibit 11: Business Segmentation of Jubiliant Life Sciences Ltd.
